Aqtual, Inc. is a precision medicine company using its novel cell-free DNA platform to develop products for chronic diseases and oncology.  Aqtual’s mission is to revolutionise chronic disease and oncology management by bridging the translational gap between groundbreaking research and practical healthcare solutions. Through proprietary biochemistry, novel technology, and advanced data science, company is building a comprehensive catalog of disease-specific clinical features and developing highly accurate blood tests for disease detection, monitoring, and patient stratification across chronic inflammatory conditions and oncology.